- Struggling DNA testing firm 23andMe to be bought for $256m BBC
- Regeneron Is Buying 23andMe. The Deal Is a Head Scratcher. Barron’s
- Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million WSJ
- Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million CNBC
- Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale GlobeNewswire